Table I.
Baseline patient characteristics (N = 83)
| Characteristic | Value |
|---|---|
| Sex, n (%) | |
| Female | 68 (81.93) |
| Male | 15 (18.07) |
| Race, n (%) | |
| White | 49 (59.04) |
| Black | 29 (34.94) |
| Hispanic/Latino | 4 (4.82) |
| Asian | 1 (1.20) |
| Age at diagnosis, years, mean (SD) | 39.12 (14.93) |
| Age at first visit, years, mean (SD) | 49.0 (12.42) |
| Predominant CLE subtype, n (%) | |
| Discoid LE | 57 (68.67) |
| Localized | 31 (37.35) |
| Generalized | 26 (31.33) |
| Subacute LE | 26 (31.33) |
| Annular | 8 (9.64) |
| Papulosquamous | 22 (26.51) |
| Systemic LE involvement, n (%) | 23 (27.71) |
| Discoid LE | 20 (24.10) |
| Localized | 7 (8.43) |
| Generalized | 13 (15.66) |
| Subacute LE | 3 (3.61) |
| Annular | 0 (0) |
| Papulosquamous | 3 (3.61) |
| Disease duration at baseline visit, years, mean (SD) | 9.81 (10.88) |
| Duration of follow-up per patient, years, mean (SD) | 3.61 (2.18) |
| No. follow-up visits per patient, mean (SD) | 7.53 (3.75) |
| Smoking status, n (%) | |
| Nonsmoker | 38 (45.78) |
| Current smoker | 33 (39.76) |
| Past smoker | 12 (14.46) |
CLE, Cutaneous lupus erythematosus; LE, lupus erythematosus; SD, standard deviation.